What is known?
- During new coronavirus pandemic, among patients with a history of
malignant tumours, lung cancer is the most common cancer, but patients
with lung cancer have no higher incidence of malignant events.
- Cytotoxic therapies should be continued under the required isolation,
multidisciplinary approach is necessary for these patients
- In a patient with respiratory symptoms, if the new coronary pneumonia
is excluded, the initiation of required treatments for other
infectious agents should not be delayed.
- For follow up patients telemedicine is a good alternative.